KIT and thymic carcinoma: On comparing thymoma and thymic carcinoma, EGFR overexpression was noted in 23% vs. 67–100%, HER2 overexpression in 6% vs. 53%, KIT overexpression in ˂5% vs. 73–86%, and BCL-2 overexpression in 14% vs. 100%, respectively [40].